Nantahala Capital Management’s Wave Life Sciences WVE Stock Holding History

Nantahala Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-819,101	Closed	-$1.64M	–	133
2022 Q1	$1.64M	Sell	819,101 -87,993	-10%	-$216K	0.07%	92
2021 Q4	$2.85M	Sell	907,094 -87,037	-9%	-$361K	0.1%	95
2021 Q3	$4.87M	Sell	994,131 -800,101	-45%	-$4.85M	0.15%	85
2021 Q2	$11.9M	Sell	1,794,232 -1,088,554	-38%	-$7.11M	0.34%	62
2021 Q1	$16.2M	Sell	2,882,786 -474,519	-14%	-$4.56M	0.47%	46
2020 Q4	$26.4M	Buy	3,357,305 +978,879	+41%	+$8.22M	0.82%	32
2020 Q3	$20.2M	Buy	2,378,426 +630,747	+36%	+$6.91M	0.62%	34
2020 Q2	$18.2M	Buy	1,747,679 +773,207	+79%	+$7.28M	0.55%	41
2020 Q1	$9.13M	Buy	+974,472	New	+$8.3M	0.34%	49

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nantahala Capital Management's WVE Position: Q2 2022 in Review

Nantahala Capital Management sold out of Wave Life Sciences (WVE) in Q2 2022, closing a stake of 819,101 shares — an estimated $1.64M sold.

Nantahala Capital Management first reported a position in WVE in Q1 2020 and held it in 9 quarters. The position peaked at $26.4M in Q4 2020. 60 funds tracked by Wall St. Rank hold WVE as of Q2 2022.

Nantahala Capital Management reported no remaining Wave Life Sciences position as of Q2 2022 after selling out during the quarter.
Nantahala Capital Management sold 819,101 Wave Life Sciences shares in Q2 2022, an estimated $1.64M.
Nantahala Capital Management first reported a position in Wave Life Sciences in Q1 2020 and held it in 9 quarters.
Nantahala Capital Management's Wave Life Sciences position peaked at $26.4M in Q4 2020.
60 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2022.

Based on Nantahala Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.